Week in Review: August 19–23

The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

MAGNY ET AL, 2013Though the human genome contains thousands of them, small open reading frames (smORFs), sequences that encode proteins with no more than 30 amino acids, have largely gone unnoticed. Juan Pablo Couso and his colleagues made a compelling case for the importance of these tiny sequences this week, showing in Science that homologous smORFs control the flow of calcium in human and fly hearts. These sequences, the researchers showed, have retained such function for more than 550 million years.

“The new work suggests that these elements are not only unknown, but also biologically interesting,” physiologist Alan Saghatelian, who was not involved in the study, told The Scientist.

WIKIMEDIA, AUDEMade in America organization co-founder G. Nagesh Rao voiced his support for the Leahy-Smith America Invents Act (AIA), batting down assertions that the legislation has led to a “first to file” system, in an opinion article this week. Rao noted that new AIA-related US Patent & Trademark Office policy offers benefits for biotech, including three types of examination procedures—accelerated, regular, or decelerated. Opting for the decelerated procedure, he said, could help biotechs maximize their patent protections following regulatory approval.

“No legislation emanating from a democracy is going to be perfect given the various stakeholders in play, but the passing of AIA was a step in the right direction for keeping the United States’ competitive edge in a globalized economy,” Rao wrote.

FLICKR, MIKE LAWRENCEAvian foragers who roam roadways adjust their takeoff timing according to local speed limits—to avoid being struck by cars, a study highlighted this week in The Scientist’s behavior research round-up found. Pierre Legagneux from the University of Quebec at Rimouski and his colleagues recorded when road-roaming birds took flight when approached by vehicles traveling at, above, and below a roadway’s speed limit. What they found suggests that birds adjust their takeoff times in order to maximize foraging time without being hit according to the average speed of all cars traveling on a given roadway, rather than the speed of any one.

WIKIMEDIAVictoria Doronina expressed disappointment with the growing push to commercialize scientific research, highlighting her personal experiences as a PhD student in the former Soviet Union and a postdoc in the UK, in an opinion article this week. Science, she argued, should not be commoditized.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies